## Abstract The insulinβlike growth factor type I receptor (IGFβIR) has been suggested to play an important role in prostate cancer progression and possibly in the progression to androgenβindependent (AI) disease. The term AI may not be entirely correct, in that recent data suggest that expression
Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
β Scribed by Grant Buchanan; Ryan A. Irvine; Gerhard A. Coetzee; Wayne D. Tilley
- Book ID
- 110337710
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 390 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0167-7659
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Androgen deprivation has been the standard therapy for advanced and metastatic prostate cancer for over half a century, as prostate tumors are initially dependent on androgens for growth and survival. Unfortunately, in most patients undergoing androgen ablation, relapse (recurrent tumor
## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.
## Abstract The androgen receptor signaling axis plays an essential role in the development, function and homeostasis of male urogenital structures including the prostate gland although the mechanism by which the AR axis contributes to the initiation, progression and metastatic spread of prostate c